Trader’s Watch List: Bellerophon Therapeutics LLC (NASDAQ:BLPH), Stereotaxis Inc. (NASDAQ:STXS), Xenoport, Inc. (NASDAQ:XNPT), Eagle Bancorp, Inc. (NASDAQ:EGBN), Ophthotech Corporation (NASDAQ:OPHT)

Bellerophon Therapeutics LLC (NASDAQ:BLPH) lock-up period is set to end on Wednesday, August 12th. Bellerophon Therapeutics had issued 5,000,000 shares in its public offering on February 13th, MarketBeat Ratings reports. The total size of the offering was $60,000,000 based on an initial share price of $12.00. After the expiration of Bellerophon Therapeutics’ lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted. Bellerophon Therapeutics LLC (NASDAQ:BLPH) belongs to Healthcare sector. Its weekly performance is -13.39%. On last trading day company shares ended up $3.30. Bellerophon Therapeutics LLC (NASDAQ:BLPH) distance from 50-day simple moving average (SMA50) is -57.05%.

Stereotaxis, Inc. (NASDAQ: STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today reported financial results for the second quarter ended June 30, 2015. Compared to a year ago, revenue for the second quarter increased 20% and revenue for the first half of 2015 increased 17%, reflecting stronger system revenue,” said William C. Mills, Stereotaxis Chief Executive Officer. “This is the third consecutive quarter in which we converted two Niobe® ES magnetic navigation system sales to revenue. At the same time, we achieved a 31% decrease in operating loss for the first six months compared to the same period a year ago.Stereotaxis Inc. (NASDAQ:STXS) shares decreased -14.52% in last trading session and ended the day at $1.06. STXS Gross Margin is 74.60% and its return on assets is -16.50%. Stereotaxis Inc. (NASDAQ:STXS) quarterly performance is -48.29%.

Xenoport, Inc. (NASDAQ:XNPT) announced financial results for the second quarter and six months ended June 30, 2015. Total revenues for the second quarter were $8.6 million, compared to $5.3 million for the same period in 2014. Net loss for the second quarter was $24.5 million, compared to a net loss of $19.4 million for the same period in 2014. At June 30, 2015, XenoPort had cash, cash equivalents and short-term investments of $170.4 million. On 05 August, Xenoport, Inc. (NASDAQ:XNPT) shares advanced 1.45% and was closed at $7.72. XNPT EPS growth in last 5 year was 18.90%. Xenoport, Inc. (NASDAQ:XNPT) year to date (YTD) performance is -11.97%.

Eagle Bancorp, Inc. (NASDAQ:EGBN) has completed the sale of assets it acquired during its purchase of Virginia Heritage Bank late last year. The parent of Eagle Bank found the Indirect Consumer Loan portfolio of Virginia Heritage Bank to be non-strategic.MainStreet Bank (OTCQB:MNSB) bought the Indirect Consumer Loan portfolio from Eagle Bank for $80 million on July 24, 2015. Eagle said it will channel those funds into its commercial loan division, improve its yield on earning assets and reduce operating expenses. Eagle Bancorp, Inc. (NASDAQ:EGBN) ended the last trading day at $44.87. Company weekly volatility is calculated as 1.94% and price to cash ratio as 3.46. Eagle Bancorp, Inc. (NASDAQ:EGBN) showed a weekly performance of 1.45%.

Ophthotech Corporation (NASDAQ:OPHT) announced that it will report its second quarter 2015 financial results on Wednesday, August 5, 2015. Following the announcement, Ophthotech’s management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company’s financial results and provide a general business update. Ophthotech Corporation (NASDAQ:OPHT) shares decreased -6.98% in last trading session and ended the day at $64.76. Its return on assets is -18.40%. Ophthotech Corporation (NASDAQ:OPHT) quarterly performance is 41.89%.

Leave a Reply

Your email address will not be published. Required fields are marked *